Divya Rao is an Analyst at Catalio Capital Management L.P.
She is currently a PhD. candidate in the Department of Chemical and Biomolecular Engineering at Johns Hopkins University. Divya’s research focuses on developing novel gene therapy strategies for treating patients with brain tumors and neurodegenerative diseases.
Divya received her B.S. in Chemical and Biomolecular Engineering from North Carolina State University.